TY - JOUR
T1 - Pneumococcal vaccination in celiac disease
AU - Mansueto, Pasquale
AU - Carroccio, Antonio
AU - Carroccio, Antonio
AU - Villanacci, Vincenzo
AU - Bonetti, Fulvio
AU - Carroccio, Antonio
AU - Casella, Giovanni
AU - Ingravalle, Fabio
AU - Monti, Claudio
AU - Abbate, Giorgio
AU - Bonetti, Fulvio
AU - Ingravalle, Fabio
AU - Bassotti, Gabrio
PY - 2019
Y1 - 2019
N2 - Introduction: Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure ingenetically predisposed subjects.Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients.Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition inboth the general population and celiac patients. Pneumococcal vaccination is the most effective meansfor its prevention.Expert opinion: In CD, evaluation of spleen function should be useful to select patients who maybenefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could beemployed: physicians could search for signs of hyposplenism on peripheral blood smear or abdominalultrasound. However, the best strategy to identify which patients will benefit from pneumococcalvaccination has not yet been defined.
AB - Introduction: Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure ingenetically predisposed subjects.Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients.Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition inboth the general population and celiac patients. Pneumococcal vaccination is the most effective meansfor its prevention.Expert opinion: In CD, evaluation of spleen function should be useful to select patients who maybenefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could beemployed: physicians could search for signs of hyposplenism on peripheral blood smear or abdominalultrasound. However, the best strategy to identify which patients will benefit from pneumococcalvaccination has not yet been defined.
UR - http://hdl.handle.net/10447/352992
M3 - Article
JO - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
JF - EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
SN - 1747-4124
ER -